macrophag
colonystimul
factor
essenti
growth
differenti
factor
cell
macrophag
lineag
explor
role
steadyst
control
monocyt
product
differenti
tissu
repair
previous
develop
bioactiv
protein
longer
halflif
circul
fuse
pig
fc
region
pig
administr
pig
expand
progenitor
pool
marrow
select
increas
monocyt
number
express
matur
marker
rapid
increas
size
liver
extens
prolifer
hepatocyt
associ
increas
macrophag
infiltr
despit
larg
influx
macrophag
evid
liver
injuri
increas
circul
liver
enzym
microarray
express
profil
liver
identifi
increas
express
macrophag
marker
ie
cytokin
tnf
known
influenc
hepatocyt
prolifer
alongsid
cell
cycl
gene
analysi
also
reveal
select
enrich
gene
associ
portal
oppos
centrilobular
region
seen
hepat
regener
combin
earlier
data
mous
studi
support
exist
feedback
loop
link
macrophag
liver
bone
marrow
blood
monocyt
mediat
homeostat
control
size
liver
result
also
provid
evid
safeti
efficaci
possibl
clinic
applic
hepatosplenomegali
macrophag
hepatostat
mcsf
studi
base
extens
studi
mous
role
monocytemacrophag
product
differenti
function
macrophag
control
hepatocyt
prolifer
use
novel
form
fc
fusion
protein
demonstr
find
mice
extend
larg
anim
discuss
possibl
role
homeostat
control
size
liver
macrophag
colonystimul
factor
essenti
growth
differenti
factor
cell
macrophag
lineag
subsequ
origin
isol
human
cdna
demonstr
inject
recombin
protein
expand
macrophag
popu
k
sauter
l
waddel
contribut
equal
work
lation
mice
number
clinic
trial
applic
cancer
indic
interest
therapeut
agent
reinvigor
evid
requir
macrophag
tissu
regener
multipl
organ
find
macrophag
gener
respons
trophic
role
treatment
shown
promot
regener
repair
injuri
model
kidney
brain
bone
pleiotrop
impact
mutat
mice
suggest
repair
tissu
reliant
macrophag
depend
growth
factor
applic
therapi
constrain
short
halflif
acid
activ
form
develop
bioactiv
protein
longer
halflif
circul
fuse
pig
equal
activ
mammalian
speci
test
fc
region
pig
expect
increas
halflif
confirm
administr
mice
produc
substanti
increas
circul
monocyt
tissu
macrophag
number
much
lower
dose
nativ
protein
unexpect
effect
treatment
substanti
increas
size
liver
associ
extens
hepatocyt
prolifer
observ
consist
previou
data
implic
macrophag
hepat
regener
acut
liver
failur
human
patient
exampl
due
paracetamol
toxic
associ
loss
clearanc
function
protect
bodi
content
portal
blood
circul
level
human
patient
upon
admiss
hospit
paracetamol
poison
found
predict
subsequ
prognosi
administr
mous
model
produc
acceler
regener
liver
perhap
importantli
rapid
restor
clearanc
function
pig
use
increasingli
model
human
diseas
gene
express
profil
stimul
mous
human
macrophag
differ
greatli
pig
macrophag
much
humanlik
asid
possibl
applic
human
diseas
model
pig
major
livestock
speci
earli
wean
pig
mucos
barrier
innat
immun
system
immatur
associ
suscept
wide
rang
mucos
system
bacteri
viral
infect
produc
signific
loss
result
obtain
mice
necessarili
extrapol
larg
anim
includ
human
profil
macrophag
activ
microbi
stimuli
differ
result
confirm
mous
drive
hepatocyt
prolifer
modul
size
liver
larg
anim
model
data
support
applic
liver
regener
provid
evid
role
monocyt
macrophag
matur
combin
earlier
data
reinforc
conclus
circul
central
contributor
homeostat
control
size
liver
anim
approv
obtain
protocol
ethic
committe
roslin
institut
agrifood
bioscienc
institut
afbi
trial
experi
carri
author
uk
home
offic
project
licens
regul
anim
scientif
procedur
act
made
previous
describ
provid
zoeti
larg
white
pig
wk
age
one
litter
use
four
day
prior
first
inject
pig
weigh
blood
collect
edta
tube
pig
inject
subcutan
day
total
day
appropri
volum
mgkg
n
pb
vehicl
n
pb
inject
use
control
possibl
impact
stress
restraint
associ
treatment
experi
weaner
larg
white
landrac
pig
wk
age
three
litter
use
six
day
prior
first
inject
pig
weigh
estim
weight
extrapol
first
inject
day
pig
inject
intramuscularli
day
day
appropri
volum
mgkg
n
pb
n
second
inject
day
pig
wean
pig
sedat
ketamin
azaperon
euthan
captiv
bolt
neither
subcutan
intramuscular
inject
produc
side
effect
isol
pbmc
bmc
blood
collect
blood
collect
bag
contain
acid
citrat
dextros
acd
sarstedt
beaker
contain
acd
sigma
buffi
coat
layer
onto
lymphoprep
axisshield
centrifug
min
g
brake
peripher
blood
mononuclear
cell
pbmc
retriev
red
cell
remov
cell
lysi
buffer
biolegend
pig
bone
marrow
cell
bmc
obtain
flush
bone
marrow
rib
mm
edta
follow
remov
red
cell
cell
lysi
buffer
isol
cell
suspend
pb
prior
count
cryopreserv
flow
cytometri
analysi
cell
wash
pellet
resuspend
block
buffer
heat
inactiv
fc
transfer
plate
vbottom
incub
ice
min
plate
centrifug
min
g
follow
remov
supernat
cell
resuspend
l
pb
contain
appropri
antibodi
isotyp
control
tabl
sampl
incub
dark
min
wash
two
time
l
pb
cell
resuspend
l
pb
sytox
blue
invitrogen
immedi
prior
analysi
use
bd
fortessa
lsr
flow
cytomet
becton
dickinson
analysi
perform
use
flowjo
softwar
flowjo
complet
blood
count
analysi
aliquot
blood
acd
blood
collect
bag
analyz
complet
blood
cell
count
total
white
blood
cell
wbc
measur
siemen
advia
analyz
wbc
differenti
count
perform
make
blood
smear
counterstain
giemsa
stain
prior
cell
cell
type
count
absolut
valu
wbc
type
determin
use
total
wbc
leukocyt
manual
platelet
count
carri
use
hemocytomet
slide
r
sv
clinic
patholog
laboratori
univers
edinburgh
plasma
analysi
plasma
analyz
r
sv
clinic
patholog
laboratori
cortisol
perform
siemen
immulit
analyz
well
larg
anim
liver
damag
profil
perform
analyz
instrument
laboratori
tissu
process
tissu
dissect
weigh
liver
spleen
kidney
place
neutral
buffer
formalin
rnalat
ambion
histolog
tissu
process
overnight
use
excelsior
tissu
processor
thermo
fisher
scientif
section
embed
paraffin
wax
prior
section
cut
mount
onto
slide
superfrost
plu
thermo
fisher
scientif
slide
dri
overnight
min
section
stain
h
e
immunohistochemistri
perform
r
sv
patholog
depart
immunohistochemistri
antigen
retriev
perform
proteinas
k
dako
min
nonspecif
protein
bind
block
use
goat
serum
vector
laboratori
min
endogen
peroxidas
activ
block
use
dako
real
peroxidas
blocker
dako
min
section
incub
min
use
mous
antipig
serotec
dilut
visual
use
secondari
reagent
dako
envis
mous
hrp
dako
min
follow
dab
newmarket
scientif
monosan
dab
substrat
kit
cat
min
dab
enhanc
min
newmarket
scientif
dab
concentr
cat
perform
r
sv
patholog
depart
stain
analyz
use
imag
j
fiji
immunohistochemistri
pcna
antigen
retriev
perform
boil
mm
sodium
citrat
buffer
nonspecif
protein
bind
block
use
goat
serum
vector
laboratori
min
endogen
peroxidas
activ
block
use
dako
real
peroxidas
blocker
dako
min
section
incub
min
use
rabbit
antihuman
abcam
dilut
visual
perform
secondari
reagent
immpress
hrp
antirabbit
igg
peroxidas
polym
min
follow
dab
newmarket
scientif
monosan
dab
substrat
kit
cat
min
dab
enhanc
min
newmarket
scientif
dab
concentr
cat
statist
analysi
data
analyz
ttest
result
present
treatment
group
mean
se
analys
perform
use
graphpad
prism
graphpad
softwar
p
valu
consid
statist
signific
microarray
total
rna
prepar
liver
sampl
use
trizol
prepar
hybrid
use
ambion
wt
express
kit
life
technolog
follow
manufactur
instruct
except
input
amount
rna
ng
input
instead
ng
hybrid
random
order
affymetrix
porcin
gene
st
array
perform
edinburgh
genom
univers
edinburgh
statist
analysi
array
data
util
partek
genom
suit
partek
network
analysi
normal
array
data
upload
softwar
biolayout
express
http
wwwbiolayoutorg
describ
previous
data
microarray
avail
gene
express
omnibu
ncbi
http
wwwncbinlmnihgovgeo
access
code
first
examin
pig
sex
litter
control
treat
group
weight
match
pair
base
mous
data
use
dose
mgkg
three
daili
treatment
follow
cull
h
final
inject
previou
studi
compar
nativ
nonfc
conjug
form
control
protein
nativ
much
shorter
halflif
dose
effect
monocytemacrophag
number
compar
directli
irrelev
fusion
protein
isotyp
control
fc
compon
howev
equival
dose
mg
depend
size
pig
would
impact
plasma
igg
concentr
mgml
treatment
macrophag
vitro
induc
proinflammatori
cytokin
keep
lack
intrins
proinflammatori
activ
evid
reaction
site
inject
treat
anim
obviou
effect
administr
hepatosplenomegali
doubl
spleenbodi
weight
ratio
increas
liverbodi
weight
ratio
day
fig
total
wbc
count
significantli
increas
mainli
due
lymphocytosi
addit
expect
monocytosi
fig
acceler
matur
macrophag
popul
peripher
blood
monocyt
implic
matur
blood
monocyt
mice
human
drive
format
nonclass
low
high
subset
human
low
mice
pig
blood
monocyt
also
separ
subset
base
express
surfac
marker
although
distinct
clear
speci
express
variou
marker
peripher
blood
monocyt
assess
flow
cytometri
stain
fig
addit
increas
total
wbc
seen
fig
proport
monocyt
detect
sirpa
increas
around
twofold
fig
proport
cell
express
also
increas
fig
increas
seen
percentag
lymphocyt
fig
bestcharacter
monocyt
matur
marker
pig
haptoglobin
receptor
also
implic
receptor
major
pig
viral
pathogen
porcin
reproduct
respiratori
syndrom
prrsv
vari
invers
express
doubl
stain
two
marker
indic
shift
profil
marker
favor
expans
cell
fig
result
consist
impact
promot
monocyt
product
releas
matur
impact
treatment
bone
marrow
next
investig
whether
abil
promot
monocytosi
associ
expans
progenitor
pool
marrow
fig
figur
b
demonstr
substanti
increas
larg
monocyt
even
greater
increas
cell
marrow
treat
anim
consist
pattern
seen
blood
asid
monocyt
progenitor
key
popul
macrophag
bone
marrow
form
center
hemopoiet
island
mice
cell
express
sialoadhesin
provid
receptor
immatur
erythrocyt
critic
success
engraft
bone
marrow
transplant
shown
fig
treatment
produc
substanti
increas
popul
pig
treatment
expand
small
percentag
cell
express
kit
marker
stem
cell
popul
fig
suggest
act
primarili
promot
proliferationexpans
commit
progenitor
bone
marrow
pig
neither
provid
use
marker
monocyt
lineag
cell
detect
larg
major
cell
fig
b
margin
increas
also
examin
express
use
either
recent
describ
monoclon
antibodi
label
evid
expans
posit
cell
popul
case
level
label
low
fig
c
suggest
receptor
may
downregul
count
pig
male
femal
inject
pb
mgkg
day
prior
euthanasia
day
blood
collect
edta
tube
postmortem
complet
blood
count
assess
perform
graph
show
mean
se
p
p
p
ttest
n
pig
per
treatment
liver
weightbodi
weight
ratio
spleen
weightbodi
weight
ratio
kidney
weightbodi
weight
ratio
b
total
wbc
count
lymphocyt
number
neutrophil
number
monocyt
number
platelet
number
origin
increas
liver
spleen
weight
treatment
caus
substanti
increas
macrophag
number
organ
detect
immunoloc
immunostain
section
liver
treatment
increas
area
quantifi
imagej
averag
less
averag
fig
spleen
treatment
even
greater
effect
caus
increas
area
averag
fig
mice
spleen
major
increas
size
could
attribut
increas
red
pulp
macrophag
also
expans
margin
zone
contrast
increas
area
appar
occupi
macrophag
suffici
explain
substanti
increas
size
liver
section
liver
stain
figur
show
imag
liver
two
control
two
pig
pig
rel
young
still
grow
accordingli
signific
ongo
prolifer
evid
stain
vast
major
nuclei
control
pig
liver
larg
round
consist
ident
hepatocyt
macrophag
nuclei
difficult
visual
histolog
section
cell
nuclei
much
smaller
ramifi
sinusoid
occasion
smaller
nuclei
visibl
sinusoid
suggest
infiltr
monocytemacrophag
also
prolif
shown
directli
mous
system
imag
fig
also
show
obviou
increas
cellular
respons
count
total
nuclei
proport
stain
repres
larg
field
anim
shown
fig
treatment
almost
doubl
total
number
nuclei
field
produc
threefold
increas
percentag
nuclei
stain
essenti
find
made
stain
prolifer
cell
nuclear
antigen
pcna
shown
section
fig
show
evid
patholog
liver
notabl
pyknot
nuclei
granulocyt
absent
granulocyt
infiltr
hallmark
tissu
injuri
includ
injuri
liver
chang
liver
might
occur
secondari
alter
gut
attribut
indirect
function
control
prolifer
differenti
gastrointestin
epithelium
treatment
pig
produc
small
signific
increas
mean
villu
length
mid
jejunum
detect
effect
ileum
cecal
base
ascend
colon
fig
also
signific
chang
goblet
cell
number
effect
liver
function
panel
biochem
test
measur
serum
enzym
bile
acid
bilirubin
protein
concentr
perform
assess
hepat
function
chang
small
increas
bile
acid
bilirubin
serum
pig
fig
margin
outsid
normal
rang
sinc
standard
enzym
indic
liver
injuri
alkalin
phosphatas
alanin
aminotransferas
transpeptidas
unchang
increas
bile
acid
probabl
reflect
increas
size
liver
examin
impact
liver
function
detail
profil
transcriptom
express
result
filter
remov
gene
detect
arbitrari
rel
intens
threshold
also
gene
differ
highest
lowest
valu
nine
sampl
second
criterion
remov
around
probe
microarray
includ
mani
hepatocytespecif
gene
product
figur
show
rel
abund
repres
exampl
known
hepatocyt
gene
product
albumin
alb
fetuin
transferrin
tf
within
total
liver
rna
pool
unchang
respons
word
infiltr
liver
macrophag
insuffici
dilut
contribut
hepatocyt
mrna
total
mrna
pool
find
consist
histolog
observ
even
state
infiltr
macrophag
appear
make
total
area
liver
henc
increas
total
liver
weight
attribut
primarili
increas
use
imagej
softwar
total
area
calcul
repres
imag
per
pig
per
organ
graph
show
mean
se
p
p
ttest
n
pig
per
treatment
control
steadyst
size
liver
hepatocyt
consist
extens
prolifer
increas
cellular
shown
fig
cluster
includ
probe
set
base
express
pattern
display
use
biolayout
express
advantag
use
cluster
approach
gene
might
appear
regul
subset
anim
appear
separ
smaller
cluster
may
reflect
interanim
variat
macrophageinduc
gene
express
document
previous
studi
pig
breed
gene
list
specif
cluster
provid
supplement
tabl
supplement
materi
articl
avail
onlin
journal
websit
function
annot
two
larg
cluster
test
use
david
supplement
tabl
cluster
set
gene
elev
pig
clearli
enrich
gene
involv
cell
cycl
innat
immun
wherea
cluster
set
reduc
pig
enrich
gene
involv
metabol
importantli
evid
among
induc
gene
express
apoptosisassoci
gene
induct
acut
phase
gene
appear
classic
granulocyt
marker
gene
mpo
figur
show
express
profil
number
gene
highlight
biolog
process
involv
cluster
fig
includ
mani
gene
shown
previous
restrict
macrophag
transcript
factor
surfac
marker
sirpa
itgam
known
gene
plau
endocyt
receptor
marco
pattern
recognit
receptor
averag
rel
contribut
cluster
macrophagespecif
gene
liver
total
rna
increas
threeto
fivefold
respons
consist
fig
mice
recruit
monocyt
express
chemokin
receptor
appar
respond
contrast
enrich
liver
mrna
treat
pig
alongsid
three
known
ligand
previous
observ
mice
monocyt
recruit
treat
liver
appar
respond
proinflammatori
signal
sinc
cluster
contain
numer
known
lpsinduc
gene
inflammatori
cytokin
tnf
interferon
target
multipl
type
interferon
target
costimul
cell
activ
cluster
also
contain
numer
cell
cycleassoci
gene
includ
pcna
key
transcript
factor
sever
cyclin
gene
increas
express
enzym
glycolysi
pfkp
pgd
pkm
gpi
gapdh
ldha
also
reflect
requir
aerob
glycolysi
prolifer
cell
cluster
fig
set
gene
reduc
pig
like
reflect
function
zonat
liver
periport
periven
region
liver
lobul
select
prolifer
cell
deriv
portal
progenitor
observ
regener
liver
includ
gene
involv
xenobiot
metabol
detoxif
notabl
famili
eg
glutathion
stransferas
eg
aldoketoreductas
eg
gluconeogen
enzym
known
enrich
periven
locat
cluster
contain
gene
regul
hepatocyt
stem
cell
indic
cell
expand
liver
unexpect
member
cluster
gene
growth
hormon
receptor
ghr
target
estrogen
androgen
ar
receptor
also
unexpect
inclus
receptor
hepatocyt
growth
factor
met
implic
regener
might
reflect
autoregul
respons
ligand
although
model
acut
liver
failur
pig
describ
may
one
path
clinic
develop
treatment
challeng
perform
suffici
replic
test
clinic
intervent
therefor
consid
altern
product
pig
commerci
pig
normal
wean
wk
gut
immatur
diarrhea
dissemin
infect
organ
escherichia
coli
streptococcu
sui
rel
common
respect
pig
studi
model
earlylif
stress
biolog
earli
wean
pig
may
also
relev
intestin
failureassoci
liver
diseas
neonat
children
weaner
pig
treat
higher
dose
mgkg
two
daili
inject
immedi
prior
wean
day
wean
follow
euthanasia
h
follow
final
inject
earli
time
point
alreadi
signific
increas
spleenbodi
weight
ratio
trend
toward
increas
liverbodi
weight
ratio
fig
number
cell
tripl
bone
marrow
fig
increas
number
macrophag
confirm
immunostain
liver
spleen
fig
time
point
signific
monocytosi
indic
marrow
expans
tissu
macrophag
prolifer
preced
monocyt
expans
like
direct
effect
repeat
treatment
larger
cohort
wean
pig
studi
conduct
high
health
statu
research
unit
reflect
commerci
practic
explicitli
remov
zinc
feed
usual
ad
reduc
weaningassoci
infect
given
product
inflammatori
cytokin
reduct
liver
treat
pig
measur
weight
gain
daili
anim
mgkg
administ
pig
two
daili
intramuscular
inject
day
day
wean
pig
kill
day
second
inject
although
pig
show
evid
mild
postwean
diarrhea
anim
group
continu
gain
weight
rapidli
fig
treat
pig
like
treat
mice
left
longer
final
inject
demonstr
hepatosplenomegali
fig
increas
number
macrophag
liver
remain
evid
day
fig
studi
extend
previou
studi
mice
examin
impact
sustain
increas
activ
monocytemacrophag
homeostasi
impact
observ
consist
known
biolog
activ
mice
impact
monocytemacrophag
number
matur
gener
inject
much
higher
dose
nativ
inject
much
larger
nativ
form
human
dose
nativ
requir
prohibit
larg
anim
although
entir
elimin
function
contribut
fc
compon
increas
circul
halflif
obviou
explan
increas
efficaci
compar
nativ
natur
socal
hepatostat
determin
liver
return
size
strictli
proport
bodi
size
continu
someth
mysteri
although
mani
candid
includ
growth
factor
inhibitor
extracellular
matrix
protein
metabolit
circul
hormon
regul
hepat
regener
unclear
function
sensor
previou
studi
made
strike
observ
treatment
mice
use
fc
conjug
increas
circul
halflif
abl
increas
size
liver
well
number
kupffer
cell
abil
quit
uniqu
present
studi
extend
find
domest
pig
anim
consider
humanlik
size
vascular
biolog
data
fig
show
major
impact
treatment
pig
increas
number
hepatocyt
extens
prolifer
total
cellular
liver
increas
even
increas
total
liver
weight
hepatocyt
prolifer
oppos
hypertrophi
also
featur
liver
regener
respons
partial
hepatectomi
made
reciproc
observ
mice
name
prolong
deplet
kupffer
cell
treatment
lead
reduct
size
liver
other
shown
liver
regener
greatli
impair
mice
mice
deplet
blood
monocyt
promot
liver
repair
infus
macrophag
portal
vein
impact
hepat
growth
mice
depend
monocyt
recruit
evid
impact
knockout
role
monocytemacrophag
product
includ
inflammatori
cytokin
tnf
hepatocyt
prolifer
well
recogn
action
mice
partli
depend
also
induc
pig
effect
treatment
demonstr
monocyt
recruit
necessari
suffici
drive
hepat
prolifer
drive
beyond
homeostat
limit
even
larg
anim
effect
treatment
support
evid
exist
homeostat
feedback
loop
macrophag
notabl
liver
blood
monocyt
togeth
regul
level
circul
via
receptormedi
endocytosi
mechan
evid
massiv
increas
circul
seen
anim
treat
import
liver
evid
patient
follow
partial
resect
treatment
reveal
elev
provok
expans
commit
monocyt
pool
marrow
fig
matur
monocyt
toward
resid
phenotyp
fig
infiltr
liver
fig
henc
physiolog
hepatostat
may
actual
macrostat
cours
increas
macrophag
number
liver
elicit
produc
secondari
impact
remov
potenti
toxin
portal
blood
alter
balanc
metabol
liver
portal
venousassoci
function
interestingli
resid
kupffer
cell
select
locat
toward
portal
vein
mous
liver
lobul
might
also
serv
local
macrophagederiv
hepatocyt
prolif
signal
express
profil
liver
pig
fig
close
parallel
result
obtain
previous
mous
system
newli
recruit
monocyt
clearli
respond
tlrmediat
signal
express
larg
major
transcript
seen
bone
mar
fig
effect
short
cours
wean
pig
pig
male
femal
inject
pb
mgkg
day
prior
euthanasia
day
graph
show
mean
se
p
p
p
ttest
n
pig
per
treatment
blood
collect
edta
tube
postmortem
complet
blood
count
assess
perform
graph
show
liver
weightbodi
weight
ratio
spleen
weightbodi
weight
ratio
monocyt
number
b
bm
rib
collect
describ
materi
method
bm
cell
analyz
via
flow
cytometri
express
exclus
dead
cell
use
sytox
blue
repres
flow
cytometri
plot
shown
c
formalinfix
liver
spleen
tissu
prepar
stain
repres
imag
shown
fig
longlast
effect
wean
pig
pig
male
femal
inject
pb
mgkg
day
prior
euthanasia
day
final
inject
n
pig
per
treatment
bodi
weight
record
time
point
shown
total
bodi
weight
chang
durat
experi
graph
pb
treat
pig
black
pig
red
b
bar
graph
show
mean
se
p
p
ttest
graph
show
liver
weightbodi
weight
ratio
spleen
weightbodi
weight
ratio
kidney
weightbodi
weight
ratio
c
formalinfix
liver
tissu
prepar
stain
repres
imag
shown
scale
bar
control
steadyst
size
liver
rowderiv
macrophag
respond
lp
howev
classic
neutrophil
chemoattract
detect
found
evid
neutrophil
infiltr
induct
classic
acut
phase
respons
apoptosi
gene
evid
damag
liver
cell
furthermor
pig
show
advers
impact
weaner
treatment
impair
rapid
growth
fig
consist
earlier
data
recombin
previous
administ
phase
clinic
trial
continu
infus
human
welltoler
indic
fc
fusion
protein
produc
addit
toxic
lack
sever
consequ
may
attribut
part
induct
antiinflammatori
cytokin
liver
treat
anim
whatev
mechan
outcom
suggest
specif
promot
proregen
cellular
respons
liver
organ
final
set
experi
fig
progress
toward
clinic
applic
pig
model
model
may
also
reflect
practic
applic
pig
product
bolster
innat
immun
system
wean
show
two
dose
administ
intramuscularli
suffici
produc
sustain
increas
monocyt
count
liver
size
liver
macrophag
number
produc
advers
local
reaction
propos
could
provid
protect
dissemin
infect
aris
immatur
gut
earlywean
anim
similarli
clearanc
function
macrophag
liver
crucial
prevent
sepsi
acut
liver
failur
human
rapidli
promot
clearanc
function
mous
diseas
model
fact
administr
pig
increas
size
liver
liver
macrophag
popul
ie
clearanc
capac
note
also
increas
express
clearanc
receptor
array
profil
obviou
relev
human
acut
liver
failur
accordingli
suggest
fundament
understand
central
role
liver
homeostasi
potenti
translat
human
clinic
veterinari
applic
